NYSE:BAX - Baxter International Stock Price, News, Headlines & Rumors

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, July 17th. Shareholders of record on Friday, August 31st will be paid a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 annualized dividend and a dividend yield of 1.06%. The ex-dividend date is Thursday, August 30th. View Baxter International's Dividend History.

Baxter International announced that its Board of Directors has authorized a share buyback plan on Wednesday, February 21st 2018, which permits the company to buyback $1,500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company's board of directors believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) announced its quarterly earnings results on Thursday, July, 26th. The medical instruments supplier reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.71 by $0.06. The medical instruments supplier had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.83 billion. Baxter International had a net margin of 8.29% and a return on equity of 16.63%. Baxter International's quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.63 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Wednesday, October, 24th 2018. View Earnings Estimates for Baxter International.

Baxter International issued an update on its FY18 earnings guidance on Thursday, July, 26th. The company provided earnings per share guidance of $2.94-3.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.89. Baxter International also updated its Q3 guidance to $0.72-0.74 EPS.

13 equities research analysts have issued 12-month price targets for Baxter International's shares. Their predictions range from $62.00 to $85.00. On average, they expect Baxter International's stock price to reach $75.6154 in the next twelve months. This suggests a possible upside of 5.6% from the stock's current price. View Analyst Price Targets for Baxter International.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hill-Rom (HRC), ICU Medical (ICUI), Integra Lifesciences (IART), Haemonetics (HAE), Globus Medical (GMED) and Insulet (PODD).

News coverage about BAX stock has been trending positive this week, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Baxter International earned a media and rumor sentiment score of 0.32 on Accern's scale. They also gave news articles about the medical instruments supplier an impact score of 47.40 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days. View Recent Headlines for Baxter International.

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.82%), FMR LLC (5.36%), Veritas Asset Management LLP (1.65%), Wells Fargo & Company MN (1.07%), Bank of New York Mellon Corp (0.82%) and Janus Henderson Group PLC (0.75%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Partner Fund Management L.P., Canada Pension Plan Investment Board, Renaissance Technologies LLC, Veritas Asset Management LLP, Great West Life Assurance Co. Can, Starboard Value LP and Schwab Charles Investment Management Inc.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Voya Investment Management LLC, Morgan Stanley, Standard Life Aberdeen plc, SPF Beheer BV, Marshall Wace LLP, Obermeyer Wood Investment Counsel Lllp and Putnam Investments LLC. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $71.58.

Baxter International has a market capitalization of $38.20 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]